Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The ideal healthcare: priorities of people with chronic conditions and their carers.
A home-based comprehensive care model in patients with Multiple Sclerosis: A study pre-protocol.
Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis.
Neuronal expression of the transcription factor serum response factor modulates myelination in a mouse multiple sclerosis model.
[Extending therapeutic possibilities in relapsing-remitting multiple sclerosis: dimethyl fumarate].
The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis.
Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: No.
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
High-density peptide microarray analysis of IgG autoantibody reactivities in serum and cerebrospinal fluid of multiple sclerosis patients.
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: utilization and valuation by patients.
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
Determination of Brain Volumes Using Quantitative MR Imaging in Patients with Multiple Sclerosis.
Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Myopathy associated with Neuromyelitis Optica Spectrum Disorders.
MyelStones: the executive roles of myelin basic protein in myelin assembly and destabilization in multiple sclerosis.
Correction: Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients.
Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
Immune surveillance of the central nervous system in multiple sclerosis - Relevance for therapy and experimental models.
Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography tandem mass spectrometry.
Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation.
Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages.
Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis.
Pain in neuromyelitis optica-prevalence, pathogenesis and therapy.
Pages
« first
‹ previous
…
628
629
630
631
632
633
634
635
636
…
next ›
last »